Fifth Third Bancorp
SLXP

Fifth Third Bancorp’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Fifth Third Bancorp’s Portfolio SLXP Stock Details SLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-20,789
Closed -$3.59M – 3014
2015
Q1 		$3.59M Sell
20,789
-15,649
-43% -$2.3M 0.03% 336
2014
Q4 		$4.19M Sell
36,438
-24,020
-40% -$2.91M 0.04% 323
2014
Q3 		$9.45M Buy
60,458
+24,378
+68% +$3.53M 0.09% 204
2014
Q2 		$4.45M Sell
36,080
-12,831
-26% -$1.42M 0.04% 308
2014
Q1 		$5.07M Buy
+48,911
New +$5.01M 0.05% 296

Other funds holding SLXP

MMG
Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

Fifth Third Bancorp's SLXP Position: Q2 2015 in Review

Fifth Third Bancorp sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 20,789 shares — an estimated $3.59M sold.

Fifth Third Bancorp first reported a position in SLXP in Q1 2014 and held it in 5 quarters. The position peaked at $9.45M in Q3 2014. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

  • Fifth Third Bancorp reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
  • Fifth Third Bancorp sold 20,789 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $3.59M.
  • Fifth Third Bancorp first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q1 2014 and held it in 5 quarters.
  • Fifth Third Bancorp's SALIX PHARMACEUTICALS LTD DEL position peaked at $9.45M in Q3 2014.
  • 1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on Fifth Third Bancorp's 13F filing for Q2 2015, filed 14 Aug 2015.